1.Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel J-F. Ulcerative colitis. The Lancet. 2017;389:1756–70.
2.Matsuoka K, Uemura Y, Kanai T, Kunisaki R, Suzuki Y, Yokoyama K, Yoshimura N, Hibi T. Efficacy of Bifidobacterium breve Fermented Milk in Maintaining Remission of Ulcerative Colitis. Digestive diseases and sciences. 2018;63:1910–9.
3.Yan L, Lianjie L, Qiushi W, Yu J, Ying Z, Yong C, Changqing Z. Transplantation of human umbilical mesenchymal stem cells attenuates dextran sulfate sodium-induced colitis in mice. Clin Exp Pharmacol Physiol. 2015;42:76–86.
4.Mijac D, Vukovic-Petrovic I, Mijac V, Perovic V, Milic N, Djuranovic S, Bojic D, Popovic D, Culafic D, Krstic M, Jankovic G, Pravica V, Markovic M. MDR1 gene polymorphisms are associated with ulcerative colitis in a cohort of Serbian patients with inflammatory bowel disease. PloS one. 2018;13:e0194536.
5.Chambers ES, Suwannasaen D, Mann EH, Urry Z, Richards DF, Lertmemongkolchai G, Hawrylowicz CM. 1alpha,25-dihydroxyvitamin D3 in combination with transforming growth factor-beta increases the frequency of Foxp3(+) regulatory T cells through preferential expansion and usage of interleukin–2. Immunology. 2014;143:52–60.
6.Greiller CL, Martineau AR. Modulation of the immune response to respiratory viruses by vitamin D. Nutrients. 2015;7:4240–70.
7.Abraham BP, Prasad P, Malaty HM. Vitamin D deficiency and corticosteroid use are risk factors for low bone mineral density in inflammatory bowel disease patients. Digestive diseases and sciences. 2014;59:1878–84.
8.Vasovic M, Gajovic N, Brajkovic D, Jovanovic M, Zdravkovaic N, Kanjevac T. The relationship between the immune system and oral manifestations of inflammatory bowel disease: a review. Central-European journal of immunology. 2016;41:302–10.
9.Nazemisalman B, Vahabi S, Sabouri E, Hosseinpour S, Doaju S. Association of vitamin D binding protein and vitamin D receptor gene polymorphisms in Iranian patients with chronic periodontitis. Odontology. 2019;107:46–53.
10.Shi J, Grundy A, Richardson H, Burstyn I, Schuetz JM, Lohrisch CA, SenGupta SK, Lai AS, Brooks-Wilson A, Spinelli JJ, Aronson KJ. Genetic variation in vitamin D-related genes and risk of breast cancer among women of European and East Asian descent. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2016;37:6379–87.
11.Schneider AL, Lutsey PL, Selvin E, Mosley TH, Sharrett AR, Carson KA, Post WS, Pankow JS, Folsom AR, Gottesman RF, Michos ED. Vitamin D, vitamin D binding protein gene polymorphisms, race and risk of incident stroke: the Atherosclerosis Risk in Communities (ARIC) study. European journal of neurology. 2015;22:1220–7.
12.Delanghe JR, Speeckaert R, Speeckaert MM. Behind the scenes of vitamin D binding protein: more than vitamin D binding. Best practice & research Clinical endocrinology & metabolism. 2015;29:773–86.
13.Villar LM, Del Campo JA, Ranchal I, Lampe E, Romero-Gomez M. Association between vitamin D and hepatitis C virus infection: a meta-analysis. World journal of gastroenterology. 2013;19:5917–24.
14.Robien K, Butler LM, Wang R, Beckman KB, Walek D, Koh WP, Yuan JM. Genetic and environmental predictors of serum 25-hydroxyvitamin D concentrations among middle-aged and elderly Chinese in Singapore. The British journal of nutrition. 2013;109:493–502.
15.Dignass A, Eliakim R, Magro F, Maaser C, Chowers Y, Geboes K, Mantzaris G, Reinisch W, Colombel JF, Vermeire S. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. Journal of Crohns & Colitis. 2012;6:965–90.
16.Walsh JS, Evans AL, Bowles S, Naylor KE, Jones KS, Schoenmakers I, Jacques RM, Eastell R. Free 25-hydroxyvitamin D is low in obesity, but there are no adverse associations with bone health. The American journal of clinical nutrition. 2016;103:1465–71.
17.Ulitsky A, Ananthakrishnan AN, Naik A, Skaros S, Zadvornova Y, Binion DG, Issa M. Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. JPEN Journal of parenteral and enteral nutrition. 2011;35:308–16.
18.Chun RF, Adams JS, Hewison M. Back to the future: a new look at ‘old’ vitamin D. The Journal of endocrinology. 2008;198:261–9.
19.Chen L, Zhou Z, Yang Y, Chen N, Xiang H. Therapeutic effect of imiquimod on dextran sulfate sodium-induced ulcerative colitis in mice. PloS one. 2017;12:e0186138.
20.Yu YR, Rodriguez JR. Clinical presentation of Crohn’s, ulcerative colitis, and indeterminate colitis: Symptoms, extraintestinal manifestations, and disease phenotypes. Seminars in pediatric surgery. 2017;26:349–55.
21.Bradley JR. TNF‐mediated inflammatory disease. Journal of Pathology. 2010;214:149–60.
22.Ludwiczek O, Vannier E, Borggraefe I, Kaser A, Siegmund B, Dinarello CA, Tilg H. Imbalance between interleukin–1 agonists and antagonists: relationship to severity of inflammatory bowel disease. Clinical and experimental immunology. 2004;138:323–9.
23.Yen D, Cheung J, Scheerens H, Poulet F, McClanahan T, McKenzie B, Kleinschek MA, Owyang A, Mattson J, Blumenschein W, Murphy E, Sathe M, Cua DJ, Kastelein RA, Rennick D. IL–23 is essential for T cell-mediated colitis and promotes inflammation via IL–17 and IL–6. The Journal of clinical investigation. 2006;116:1310–6.
24.Hue S, Ahern P, Buonocore S, Kullberg MC, Cua DJ, McKenzie BS, Powrie F, Maloy KJ. Interleukin–23 drives innate and T cell-mediated intestinal inflammation. The Journal of experimental medicine. 2006;203:2473–83.
25.Cuenda A, Rousseau S. p38 MAP-kinases pathway regulation, function and role in human diseases. Biochimica et biophysica acta. 2007;1773:1358–75.
26.Espaillat MP, Kew RR, Obeid LM. Sphingolipids in neutrophil function and inflammatory responses: Mechanisms and implications for intestinal immunity and inflammation in ulcerative colitis. Advances in biological regulation. 2017;63:140–55.
27.Pugliese D, Felice C, Papa A, Gasbarrini A, Rapaccini GL, Guidi L, Armuzzi A. Anti TNF-alpha therapy for ulcerative colitis: current status and prospects for the future. Expert review of clinical immunology. 2017;13:223–33.
28.Liu Z, Yadav PK, Xu X, Su J, Chen C, Tang M, Lin H, Yu J, Qian J, Yang PC, Wang X. The increased expression of IL–23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity. Journal of leukocyte biology. 2011;89:597–606.
29.Mohammadi E, Qujeq D, Taheri H, Hajian-Tilaki K. Evaluation of Serum Trace Element Levels and Superoxide Dismutase Activity in Patients with Inflammatory Bowel Disease: Translating Basic Research into Clinical Application. Biological trace element research. 2017;177:235–40.
30.Parikh B, Patel VH. Total phenolic content and total antioxidant capacity of common Indian pulses and split pulses. Journal of food science and technology. 2018;55:1499–507.
31.Zhang Q, Tao H, Lin Y, Hu Y, An H, Zhang D, Feng S, Hu H, Wang R, Li X, Zhang J. A superoxide dismutase/catalase mimetic nanomedicine for targeted therapy of inflammatory bowel disease. Biomaterials. 2016;105:206–21.
32.Chen XE, Chen P, Chen SS, Lu J, Ma T, Shi G, Zhou Y, Li J, Sheng L. A population association study of vitamin D receptor gene polymorphisms and haplotypes with the risk of systemic lupus erythematosus in a Chinese population. Immunologic research. 2017;65:750–6.
33.O’Brien KM, Sandler DP, Kinyamu HK, Taylor JA, Weinberg CR. Single-Nucleotide Polymorphisms in Vitamin D-Related Genes May Modify Vitamin D-Breast Cancer Associations. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2017;26:1761–71.
34.Simon G, Ian L. The role of vitamin D in gastrointestinal inflammation. Expert Review of Gastroenterology & Hepatology. 2014;8:1.
35.Reich KM, Fedorak RN, Madsen K, Kroeker KI. Vitamin D improves inflammatory bowel disease outcomes: basic science and clinical review. World journal of gastroenterology. 2014;20:4934–47.
36.Chun RF. New perspectives on the vitamin D binding protein. Cell biochemistry and function. 2012;30:445–56.
37.Carlberg C, Campbell MJ. Vitamin D receptor signaling mechanisms: integrated actions of a well-defined transcription factor. Steroids. 2013;78:127–36.
38.YY Luo SC, JD Yu, et al. Vitamin D Metabolism-related Gene Polymorphisms in Crohn’s Disease. HK J PAEDIATR. 2016;21:162–7.
39.Braithwaite VS, Jones KS, Schoenmakers I, Silver M, Prentice A, Hennig BJ. Vitamin D binding protein genotype is associated with plasma 25OHD concentration in West African children. Bone. 2015;74:166–70.
40.Xu W, Sun J, Wang W, Wang X, Jiang Y, Huang W, Zheng X, Wang Q, Ning Z, Pei Y, Nie M, Li M, Wang O, Xing X, Yu W, Lin Q, Xu L, Xia W. Association of genetic variants of vit D binding protein (DBP/GC) and of the enzyme catalyzing its 25-hydroxylation (DCYP2R1) and serum vit D in postmenopausal women. Hormones (Athens, Greece). 2014;13:345–52.
41.Zhang Z, He JW, Fu WZ, Zhang CQ, Zhang ZL. An analysis of the association between the vitamin D pathway and serum 25-hydroxyvitamin D levels in a healthy Chinese population. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research. 2013;28:1784–92.
42.Li LH, Yin XY, Wu XH, Zhang L, Pan SY, Zheng ZJ, Wang JG. Serum 25(OH)D and vitamin D status in relation to VDR, GC and CYP2R1 variants in Chinese. Endocrine journal. 2014;61:133–41.
43.Bhan I. Vitamin d binding protein and bone health. International journal of endocrinology. 2014;2014:561214.
44.Li F, Jiang L, Willis-Owen SA, Zhang Y, Gao J. Vitamin D binding protein variants associate with asthma susceptibility in the Chinese Han population. BMC medical genetics. 2011;12:103.
45.Malecki MT, Klupa T, Wanic K, Cyganek K, Frey J, Sieradzki J. Vitamin D binding protein gene and genetic susceptibility to type 2 diabetes mellitus in a Polish population. Diabetes research and clinical practice. 2002;57:99–104.
46.Kurylowicz A, Ramos-Lopez E, Bednarczuk T, Badenhoop K. Vitamin D-binding protein (DBP) gene polymorphism is associated with Graves’ disease and the vitamin D status in a Polish population study. Experimental and clinical endocrinology & diabetes: official journal, German Society of Endocrinology [and] German Diabetes Association. 2006;114:329–35.
47.Eloranta JJ, Wenger C, Mwinyi J, Hiller C, Gubler C, Vavricka SR, Fried M, Kullak-Ublick GA. Association of a common vitamin D-binding protein polymorphism with inflammatory bowel disease. Pharmacogenetics and genomics. 2011;21:559–64.
48.Samsamikor M, Daryani NE, Asl PR, Hekmatdoost A. Resveratrol Supplementation and Oxidative/Anti-Oxidative Status in Patients with Ulcerative Colitis: A Randomized, Double-Blind, Placebo-controlled Pilot Study. Archives of medical research. 2016;47:304–9.
49.Sandborn WJ, Travis S, Moro L, Jones R, Gautille T, Bagin R, Huang M, Yeung P, Ballard ED, 2nd. Once-daily budesonide MMX(R) extended-release tablets induce remission in patients with mild to moderate ulcerative colitis: results from the CORE I study. Gastroenterology. 2012;143:1218–26.e2.
50.Lin JL, Thomas PS. Current perspectives of oxidative stress and its measurement in chronic obstructive pulmonary disease. Copd. 2010;7:291–306.
51.Ha YM, Kim MY, Park MK, Lee YS, Kim YM, Kim HJ, Lee JH, Chang KC. Higenamine reduces HMGB1 during hypoxia-induced brain injury by induction of heme oxygenase–1 through PI3K/Akt/Nrf–2 signal pathways. Apoptosis: an international journal on programmed cell death. 2012;17:463–74.
52.Lee IA, Bae EA, Hyun YJ, Kim DH. Dextran sulfate sodium and 2,4,6-trinitrobenzene sulfonic acid induce lipid peroxidation by the proliferation of intestinal gram-negative bacteria in mice. Journal of inflammation (London, England). 2010;7:7.
53.Lu M, Xia L, Luo D, Waxman S, Jing Y. Dual effects of glutathione-S-transferase pi on As2O3 action in prostate cancer cells: enhancement of growth inhibition and inhibition of apoptosis. Oncogene. 2004;23:3945–52.
54.Chen G, Yang Y, Hu C, Cheng X, Xu Y, Cai X, Wang M, Yang CS, Cao P. Protective effects of Huangqin Decoction against ulcerative colitis and associated cancer in mice. Oncotarget. 2016;7:61643–55.